Sug H. Lee

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 214 publications

NatD promotes glioblastoma progression through epigenetic activation of FGFR4 signalling.

NatD promotes glioblastoma progression through epigenetic activation of FGFR4 signalling.

Journal: Experimental & molecular medicine

Published: March 22, 2026

NF-κB-active tumors with matrix CAFs and suppressive immunity as key resistance mechanisms to chemoradiation in rectal cancer.

NF-κB-active tumors with matrix CAFs and suppressive immunity as key resistance mechanisms to chemoradiation in rectal cancer.

Journal: Experimental & molecular medicine

Published: March 12, 2026

Cellular responses to neoadjuvant FOLFOX6-bevacizumab treatment in colorectal cancers analyzed by single-cell transcriptome analysis.

Cellular responses to neoadjuvant FOLFOX6-bevacizumab treatment in colorectal cancers analyzed by single-cell transcriptome analysis.

Journal: Pathology, research and practice

Published: September 30, 2024

Different inflammatory, fibrotic, and immunological signatures between pre-fibrotic and overt primary myelofibrosis.

Different inflammatory, fibrotic, and immunological signatures between pre-fibrotic and overt primary myelofibrosis.

Journal: Haematologica

Published: April 12, 2024

Regional bias of tumor suppressor gene mutations of STARD8 and WNK2 in colon cancers.

Regional bias of tumor suppressor gene mutations of STARD8 and WNK2 in colon cancers.

Journal: Pathology, research and practice

Published: November 03, 2023

Intratumoral IL-12 delivery via mesenchymal stem cells combined with PD-1 blockade leads to long-term antitumor immunity in a mouse glioblastoma model.

Intratumoral IL-12 delivery via mesenchymal stem cells combined with PD-1 blockade leads to long-term antitumor immunity in a mouse glioblastoma model.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: August 09, 2023

Leprosy-specific subsets of macrophages and Schwann cells identified by single-cell RNA-sequencing.

Leprosy-specific subsets of macrophages and Schwann cells identified by single-cell RNA-sequencing.

Journal: Pathology, research and practice

Published: August 07, 2023

Frameshift mutations of immunomodulatory BTN2A1, BTN2A2, and BTNL3 genes in colon cancers.

Frameshift mutations of immunomodulatory BTN2A1, BTN2A2, and BTNL3 genes in colon cancers.

Journal: Pathology, research and practice

Published: July 09, 2023

Spatial architectures of somatic mutations in normal prostate, benign prostatic hyperplasia and coexisting prostate cancer.

Spatial architectures of somatic mutations in normal prostate, benign prostatic hyperplasia and coexisting prostate cancer.

Journal: Experimental & molecular medicine

Published: July 05, 2023

Single-cell RNA sequencing reveals a pro-metastatic subpopulation and the driver transcription factor NFE2L1 in ovarian cancer cells.

Single-cell RNA sequencing reveals a pro-metastatic subpopulation and the driver transcription factor NFE2L1 in ovarian cancer cells.

Journal: Genes & genomics

Published: June 08, 2023

Establishment of tumor microenvironment-preserving organoid model from patients with intracranial meningioma.

Establishment of tumor microenvironment-preserving organoid model from patients with intracranial meningioma.

Journal: Cancer cell international

Published: May 09, 2023

Genes with dual proto-oncogene and tumor suppressor gene activities are frequently altered by protein losses in colon cancers.

Genes with dual proto-oncogene and tumor suppressor gene activities are frequently altered by protein losses in colon cancers.

Journal: Pathology, research and practice

Published: April 26, 2023

Showing 1-12 of 214

Last Updated: 09/26/2026